I am a physicist specializing in MRI in the Imaging and Spectroscopic Physics section of the Department of Medical Physics. I have expertise in imaging techniques such as functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), and dynamic contrast-enhanced (DCE) perfusion MRI. The primary focus of my clinical work is in treatment planning for patients with brain cancer, using fMRI and DTI to enhance the safety of neurosurgical procedures.
In my research, I use fMRI and DTI to describe the function and structure of human motor and language systems, and to study how these systems are affected in patients with brain cancer. I also work with neuroradiologists to study how metastatic spinal bone marrow cancer responds to radiation and surgical therapy using DCE perfusion MRI.
Three times a year, my fMRI laboratory teaches a course for neuroradiologists called “Hands-on Clinical Functional MRI and Diffusion Tractography.” In addition, I give lectures on fMRI, during which I teach attendees the basic principles of fMRI data processing and analysis and how to solve problems in clinical fMRI data.
Education
- Post-Doc, University of Florida, USA, 2001-2003
- PhD, University of Nottingham, England, 2001
- MSc Diploma, University of Birmingham, England, 1995
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Kyung Peck discloses the following relationships and financial interests:
-
fMRI Consultants, LLC
Professional Services and Activities
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.
View all disclosures